SCHEMBL1129051

SCHEMBL1129051

Cc1ccc2[nH]c(C(C)(C)Cl)nc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ GAA P10253 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ SCN10A Q9Y5Y9 1/20 0.37
▸ NQO2 P16083 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4349193 0.88 KMT2A (0.41) KMT2ACYP1A2MAPTMEN1CYP2C9
SCHEMBL14601538 0.87 KMT2A (0.43) KMT2ACYP1A2MAPTMEN1CYP2C9
SCHEMBL1129034 0.86 KDM4E (0.53) KMT2ACYP1A2MAPTKDM4EPOLB
SCHEMBL10005347 0.86 ALDH1A1 (0.46) KMT2ACYP1A2MAPTMEN1CYP2C9
SCHEMBL1129264 0.81 NPSR1 (0.39) KMT2ACYP1A2MAPTMEN1CYP2C9
SCHEMBL171627 0.81 KDM4E (0.60) KMT2ACYP1A2MAPTMEN1CYP2C9
SCHEMBL18862125 0.77 ALDH1A1 (0.39) KMT2ACYP1A2MAPTMEN1CYP2C9
SCHEMBL3490546 0.74 KMT2A (0.44) KMT2ACYP1A2MAPTMEN1CYP2C9
SCHEMBL1171203 0.74 NPC1 (0.51) KMT2ACYP1A2MAPTMEN1CYP2C9
SCHEMBL12540 0.74 ALDH1A1 (0.50) KMT2ACYP1A2MAPTMEN1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282762-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION Intermune, Inc. (US) 2011-02-16 — — EP disclosed
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 — — WO disclosed
Send feedback